These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 7780241)
1. Interleukin-1 receptor antagonist in the fetomaternal compartment. Bry K; Teramo K; Lappalainen U; Waffarn F; Hallman M Acta Paediatr; 1995 Mar; 84(3):233-6. PubMed ID: 7780241 [TBL] [Abstract][Full Text] [Related]
2. Influence of fetal gender on the concentration of interleukin-1 receptor antagonist in amniotic fluid and in newborn urine. Bry K; Lappalainen U; Waffarn F; Teramo K; Hallman M Pediatr Res; 1994 Jan; 35(1):130-4. PubMed ID: 8134191 [TBL] [Abstract][Full Text] [Related]
3. The natural interleukin-1 receptor antagonist in the fetal, maternal, and amniotic fluid compartments: the effect of gestational age, fetal gender, and intrauterine infection. Romero R; Gomez R; Galasso M; Mazor M; Berry SM; Quintero RA; Cotton DB Am J Obstet Gynecol; 1994 Oct; 171(4):912-21. PubMed ID: 7943101 [TBL] [Abstract][Full Text] [Related]
4. Interleukin-6 and interleukin-1 receptor antagonist in amniotic fluid and cord blood in patients with pre-term, premature rupture of the membranes. Fukuda H; Masuzaki H; Ishimaru T Int J Gynaecol Obstet; 2002 May; 77(2):123-9. PubMed ID: 12031562 [TBL] [Abstract][Full Text] [Related]
5. Polymorphism in intron 2 of the fetal interleukin-1 receptor antagonist genotype influences midtrimester amniotic fluid concentrations of interleukin-1beta and interleukin-1 receptor antagonist and pregnancy outcome. Witkin SS; Vardhana S; Yih M; Doh K; Bongiovanni AM; Gerber S Am J Obstet Gynecol; 2003 Nov; 189(5):1413-7. PubMed ID: 14634579 [TBL] [Abstract][Full Text] [Related]
6. Interleukin-1 receptor antagonist in neonates, children and adults, and in patients with pauci- and polyarticular onset juvenile chronic arthritis. Müller K; Zak M; Nielsen S; Pedersen FK; de Nully P; Bendtzen K Clin Exp Rheumatol; 1997; 15(4):439-44. PubMed ID: 9272308 [TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibody based enzyme-linked and chemiluminescent assays for the human interleukin-1 receptor antagonist. Application to measure hIL-1ra levels in monocyte cultures and synovial fluids. Towbin H; Schmitz A; van Oostrum J; Seitz M; Dewald B; Zingel O; Motz J; Vosbeck K; Rordorf C J Immunol Methods; 1994 Mar; 170(1):125-35. PubMed ID: 8157985 [TBL] [Abstract][Full Text] [Related]
8. Frigen II improves the reliability of measurement of interleukin-1 related substances in amniotic fluid. Ishihara O; Saitoh M; Kinoshita K; Takanashi H; Arai Y; Kitagawa H Acta Obstet Gynecol Scand; 1999 Apr; 78(4):321-5. PubMed ID: 10203300 [TBL] [Abstract][Full Text] [Related]
9. [Prognostic values of serum concentration and urinary excretion of interleukin-1 receptor antagonist and tumor necrosis factor receptors type I and II in patients with IGA nephropathy]. Zwiech R; Kacprzyk F; Szuflet A; Nowicki M Pol Arch Med Wewn; 2005 Apr; 113(4):326-33. PubMed ID: 16209246 [TBL] [Abstract][Full Text] [Related]